Literature DB >> 7351717

Salvage cystectomy after irradiation failure.

E D Crawford, D G Skinner.   

Abstract

Recent clinical studies have revealed the superiority of planned preoperative irradiation therapy followed by cystectomy compared to either treatment modality alone. There remains a select group of patients who for personal or medical reasons are not candidates for planned preoperative irradiation and cystectomy, and these patients undergo radical irradiation therapy as the sole treatment modality. Nearly 80% of these patients with invasive bladder cancer treated by definitive irradiation therapy will fail within 5 years, and many of these might become candidates for salvage cystectomy. Our 37 consecutive patients who failed definitive irradiation therapy were treated by salvage cystectomy. The selection for the operative procedure, morbidity and mortality, and survival data are reviewed. The mortality rate for this group was 8.1% and the early complication rate was 24%. However, none of the patients who underwent a 2-stage procedure or who had an early perineal approach died. In addition, only 1 (7%) of the staged patients had an early complication. The over-all survival for the entire group of 37 patients was 38%. However, those patients with pathological stage O or A disease had a 63% survival compared to a dismal 19% for those with stage B or greater disease. Our experience leads us to recommend that salvage cystectomy be performed early after irradiation failure. Selective use of the initial perineal approach in male patients and the use of staged cystectomy after urinary diversion in some of these high risk patients have resulted in a marked decrease in the morbidity and mortality.

Entities:  

Mesh:

Year:  1980        PMID: 7351717     DOI: 10.1016/s0022-5347(17)55765-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

1.  Morbidity and mortality of radical cystectomy (1971-78 and 1978-85).

Authors:  W F Hendry
Journal:  J R Soc Med       Date:  1986-07       Impact factor: 5.344

Review 2.  Pelvic complications after interstitial and external beam irradiation of urologic and gynecologic malignancy.

Authors:  P F Schellhammer; G H Jordan; A M el-Mahdi
Journal:  World J Surg       Date:  1986-04       Impact factor: 3.352

3.  Role of lymphadenectomy for invasive bladder cancer.

Authors:  Faysal A Yafi; Wassim Kassouf
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

4.  Role of pelvic lymphadenectomy in the treatment of bladder cancer: a mini review.

Authors:  Ja Hyeon Ku
Journal:  Korean J Urol       Date:  2010-06-21

5.  Indication of radical cystectomy in patients with carcinoma of the bladder.

Authors:  W de Riese; P Esk; E Schindler
Journal:  Int Urol Nephrol       Date:  1987       Impact factor: 2.370

6.  Radical cystectomy over the age of 75 is safe and increases survival.

Authors:  Stavros I Tyritzis; Ioannis Anastasiou; Konstantinos G Stravodimos; Aristeides Alevizopoulos; Anastasios Kollias; Antonios Balangas; Ioannis Katafigiotis; Ioannis Leotsakos; Dionysios Mitropoulos; Constantinos A Constantinides
Journal:  BMC Geriatr       Date:  2012-04-30       Impact factor: 3.921

7.  Incidence and outcome of salvage cystectomy after bladder sparing therapy for muscle invasive bladder cancer: a systematic review and meta-analysis.

Authors:  Victor M Schuettfort; Benjamin Pradere; Fahad Quhal; Hadi Mostafaei; Ekaterina Laukhtina; Keiichiro Mori; Reza Sari Motlagh; Margit Fisch; David D'Andrea; Michael Rink; Paolo Gontero; Francesco Soria; Shahrokh F Shariat
Journal:  World J Urol       Date:  2020-09-29       Impact factor: 4.226

8.  Hybrid procedure using perineal and abdominal approaches for radical prostatocystectomy: initial experience with 16 select cases.

Authors:  Yozo Mitsui; Hiroaki Yasumoto; Haruki Anjiki; Chiaki Koike; Naoko Arichi; Takeo Hiraoka; Masahiro Sumura; Satoshi Honda; Mikio Igawa; Hiroaki Shiina
Journal:  Springerplus       Date:  2013-07-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.